Ticker > Company >

Kerala Ayurveda share price

Kerala Ayurveda Ltd.

BSE: 530163 SECTOR: Pharmaceuticals & Drugs  36k   42   1

483.35
-11.75 (-2.37%)
BSE: 13 Jun 04:01 PM

Price Summary

Today's High

₹ 508

Today's Low

₹ 475

52 Week High

₹ 515

52 Week Low

₹ 250

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

581.59 Cr.

Enterprise Value

626.92 Cr.

No. of Shares

1.2 Cr.

P/E

0

P/B

26.44

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  18.28

CASH

16.48 Cr.

DEBT

61.81 Cr.

Promoter Holding

58.58 %

EPS (TTM)

₹  -11.45

Sales Growth

15.55%

ROE

-1.07 %

ROCE

5.04%

Profit Growth

-109.38 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year15.55%
3 Year19.18%
5 Year9.49%

Profit Growth

1 Year-109.41%
3 Year24.68%
5 Year-176.13%

ROE%

1 Year-1.07%
3 Year13.2%
5 Year-1.29%

ROCE %

1 Year5.04%
3 Year8.38%
5 Year5.65%

Debt/Equity

1.5747

Price to Cash Flow

-137.85

Interest Cover Ratio

1.1062

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 58.58 13.36
Dec 2024 58.58 13.36
Sep 2024 58.58 13.36
Jun 2024 58.58 13.36
Mar 2024 58.58 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 19.1835457888445% for the Past 3 years.
  • The company has an efficient Cash Conversion Cycle of -13.4218 days.
  • Company has a healthy liquidity position with current ratio of 2.016.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 19.2916094762421.

 Limitations

  • Company has negative cash flow from operations of -4.219.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 17.12 15.4 18.6 19.35 19.35
Total Expenditure 16.5 16.8 19.15 18.99 30.34
Operating Profit 0.62 -1.41 -0.55 0.37 -11
Other Income 3 0.27 0.39 0.13 4.37
Interest 3.08 0.4 0.33 0.38 2.81
Depreciation 1.01 0.19 0.22 0.28 1.46
Exceptional Items -0.53 0 0 0 0
Profit Before Tax -1 -1.73 -0.71 -0.16 -10.88
Tax -0.6 -0.43 -0.17 -0.08 0.98
Profit After Tax -0.39 -1.29 -0.54 -0.08 -11.86
Adjusted EPS (Rs) -0.33 -1.08 -0.45 -0.07 -9.86

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 53.68 43.2 55.8 63.3 73.14
Total Expenditure 50.58 43 48.07 58.54 68.13
Operating Profit 3.11 0.21 7.73 4.76 5.01
Other Income 0.16 0.17 0.3 0.23 0.21
Interest 1.37 6.14 6.03 4.81 4.02
Depreciation 0.68 0.82 0.77 0.64 0.77
Exceptional Items 0 0 0 2.83 0
Profit Before Tax 1.22 -6.58 1.23 2.37 0.43
Tax 0.34 -1.63 0.35 -0.52 0.7
Net Profit 0.88 -4.95 0.89 3.26 -0.31
Adjusted EPS (Rs.) 0.83 -4.69 0.84 2.74 -0.23

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 10.56 10.56 10.56 10.56 12.03
Total Reserves 4.11 -0.51 0.72 3.98 30.34
Borrowings 47.16 47.85 28.76 48.92 51.64
Other N/C liabilities 9.49 7.83 4.16 3.75 5.07
Current liabilities 22.28 29.79 47.13 30.61 24.78
Total Liabilities 93.6 95.51 91.33 97.81 123.86
Assets
Net Block 17.09 16.8 27.96 30.32 30.25
Capital WIP 11.55 11.98 2.34 0 0
Intangible WIP 0 0 0 0 0
Investments 11.47 11.37 11.37 11.37 11.37
Loans & Advances 23.03 24.5 22.07 27.12 28.99
Other N/C Assets 3.08 3.07 4.19 3.04 3.3
Current Assets 27.38 27.8 23.39 25.97 49.96
Total Assets 93.6 95.51 91.33 97.81 123.86
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 2.44 -0.53 7.12 6.81 4.25
Adjustment 0.82 0.97 0.81 0.95 0.57
Changes in Assets & Liabilities 1.45 -1.35 0.82 1.35 -9.04
Tax Paid 0 0 0 0 0
Operating Cash Flow 4.71 -0.91 8.75 9.12 -4.22
Investing Cash Flow -3.93 -2.1 0.83 -5.32 -2.18
Financing Cash Flow 0.29 2.18 -10.52 -2.27 21.15
Net Cash Flow 1.06 -0.83 -0.94 1.52 14.75

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 58.58 58.58 58.58 58.58 58.58
katra holdings ltd 53.97 53.97 53.97 53.97 53.97
katra phytochem (india) p... - 4.61 4.61 4.61 4.61
katra phytochem india pri... 4.61 - - - -
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 41.42 41.42 41.42 41.42 41.42
anil kumar k - 1.59 1.57 1.55 1.53
dheeraj kumar lohia 2.03 2.03 2.03 2.03 1.93
llp 0.60 0.56 - 0.55 0.55
porinju veliyath 5.18 5.18 5.18 5.18 5.18
sanjiv dhireshbhai shah... - 2.89 2.89 2.89 2.55
sashikanth balachandar 1.26 1.26 1.26 1.26 1.26
anilkumar k 1.60 - - - -
sanjiv dhireshbhai shah 2.89 - - - -

Annual Reports

Title Action
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY ACTION
No Credit reports exist for this company.Report us
TYPE AGENCY ACTION
No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER ACTION
Currently we do not have any Concall related to this company.Report us
TYPE QUARTER ACTION
Currently we do not have any Presentation related to this company.Report us

Company News

 No Latest News available for this company.
Report us

Kerala Ayurveda Stock Price Analysis and Quick Research Report. Is Kerala Ayurveda an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Kerala Ayurveda and its performance over the period of time. Kerala Ayurveda stock price today is Rs 483.35.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Kerala Ayurveda cash from the operating activity was Rs -4.219 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Kerala Ayurveda has a Debt to Equity ratio of 1.5747 , which is a weak indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Kerala Ayurveda , the EPS growth was -108.2308 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Kerala Ayurveda has OPM of 6.84470585661706 % which is a bad sign for profitability.
     
  • ROE: Kerala Ayurveda have a poor ROE of -1.0653 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Kerala Ayurveda is Rs 483.35. One can use valuation calculators of ticker to know if Kerala Ayurveda share price is undervalued or overvalued.
Last Updated on:
Brief about Kerala Ayurveda
X